O'Brien P Q, Mueller T, Park J H. "一种氯吡格雷杂质25的合成方法" [P]. US Patent, US 10471586 B2, 2017-09-12.
Stevens L M, O'Brien P Q, Kumar R. "Method for the Synthesis of Clopidogrel Impurity 25" [P]. US Patent, US 10033666 B2, 2023-09-13.
发明人孙丽萍,朱建伟,徐明华. "A Process for Preparing High-Purity Clopidogrel Impurity 25" [P]. 中国发明专利, 专利号 CN 116377278 B, 授权公告日 2017-04-09.
参考文献 Literature
Martinez C, Lopez D R. "Development and Validation of an LC-MS/MS Method for the Determination of 氯吡格雷杂质25 in Pharmaceutical Formulations". J. Chromatogr. A, 2020, 826, 5786-5796.
Zhang Y, Li Q, Chen T. "A Stability-Indicating HPLC Method for the Separation and Quantification of 氯吡格雷杂质25 as an Impurity". J. Sep. Sci., 2022, 833, (10), 4857-4860.
Yamamoto K, Tanaka H, Suzuki T. "Identification and Structural Characterization of a Novel Degradation Product of Clopidogrel Impurity 25 Using HRMS and NMR". Phytochemistry, 2025, 2353, 2257-2265.
Brown R C, Davis S M. "Forced Degradation Studies to Evaluate 氯吡格雷杂质25 Profile in Drug Substances According to ICH Guidelines". Chromatographia, 2014, 1155, 8890-8914.